Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Evaluation of the Safety and Performance of the Aesthetic Medical Device MEC REGENERATE® (Injectable Recombinant Collagen-based Product)

NCT07413445 is registered in ClinicalTrials.gov with 303 Pharma s.r.l. as lead sponsor.

NCT NCT07413445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07413445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Evaluation of the Safety and Performance of the Aesthetic Medical Device MEC REGENERATE® (Injectable Recombinant Collagen-based Product)
Lead sponsor
303 Pharma s.r.l.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
May 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

laxity; skin, volume deficiency in the mid-face, wrinkles